Tbet- NK cells expressed higher levels of molecules that were increased in the general CD56bright NK cluster of MS patients (Figure 3a), and were the dominant CD56bright cell type in MS but not in control or dementia cases (Figure 3—figure supplement 2c). This evidence concerns the gene TBX21 and myeloid sarcoma.